Submit Manuscript now
Impact Factor 2.6

Month: June 2022

Peptic Ulcer Associated with Polycythemia Rubra Vera: A Case Report

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract Polycythemia Vera (PV) is a blood disorders known as myeloproliferative disease. Gastric and duodenal ulcer is a frequent disease among population but rarely is a complication of myeloproliferative disorders. Its main etiologies are inbalance of gastric acid secretion and mucosa protection. The complication of PV by an ulcer is a possible but not …

Peptic Ulcer Associated with Polycythemia Rubra Vera: A Case Report Read More »

Cancer from an Unknown Primary Source

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract The diagnosis of Cancer of Unknown Primary is difficult even in the present era of modern medicine. The incidence is closed to 2-5% of all epithelial cancers. There is no concrete explanation behind the development of these cancers, however, recent studies suggested the role of chromosomal abnormalities and neoangiogenesis in the development. Overall, …

Cancer from an Unknown Primary Source Read More »

Diagnostic Evaluation of Endoscopic Ultrasonography with and without Submucosal Saline Injection for Differentiating Between T1a and T1b Early Gastric Cancer

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract 1.1. Background Endoscopic ultrasonography (EUS) has become a reliable method for predicting the invasion depth of early gastric cancer (EGC). However, diagnostic accuracy of EUS is affected by several factors. In particular, it is difficult to differentiate between T1a and T1b EGC through EUS. The aim of this study was to confirm whether …

Diagnostic Evaluation of Endoscopic Ultrasonography with and without Submucosal Saline Injection for Differentiating Between T1a and T1b Early Gastric Cancer Read More »

Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract 1.1. Background Oncological survival after operation of resectable pancreatic ductal adenocarcinoma (R-PDAC) is variable depending on various factors. Preoperative risk stratification could guide decision-making in multidisciplinary treatment concepts. We develop and validate a prognostic score for disease-free survival (DFS) in R-PDAC to solve this issue.

Prediction of Effective Percutaneous Transhepatic Biliary Drainage in Patients with Hepatocellular Carcinoma

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract 1.1. Purpose Percutaneous transhepatic biliary drainage (PTBD) does not always lead to a reduction in serum total bilirubin level (TBil) in patients with hepatocellular carcinoma who have Hepatitis B virus-related cirrhosis and obstructive jaundice. We aimed to develop a model for pre-PTBD prediction of post-procedural TBil decrease in these patients.

Coexistence of Infantile Crohn and Humoral Immunodeficiency: A Case Report

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract Infantile inflammatory bowel disease (IBD) is a kind of IBD that begins in early childhood. However, this subgroup is rare, it is important to detect these patients early. Infantile IBD patients may have more surgical interventions and have a greater failure rate of standard therapy. In this disorder, monogenic mutations are essential. We …

Coexistence of Infantile Crohn and Humoral Immunodeficiency: A Case Report Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.